NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of UroGen Pharma Ltd. (NASDAQ: URGN)?Did you purchase your shares between July 27, 2023 and May 15, 2025, inclusive?Did you lose money i ...